Comparative study between misoprostol and lidocaine before intrauterine contraceptive device insertion

Abstract

Background Intrauterine contraceptive device (IUCD) is a safe, extremely effective and long-acting reversible contraceptive method. Misoprostol has definite to be a very pliable and adequate drug because its composition as a tablet that is stable and may be delivered orally, rectally or vaginally, and through the sublingual route. Lidocaine is a common local anesthetic and antiarrhythmic drug. Aims The objective of the present study was to compare between sublingual administration of misoprostol and lidocaine spray prior to IUCD insertion. Patients and methods This randomized controlled clinical trial was conducted at Department of Family Planning at Tanta University Hospital from February 2021 to March 2022. The study included 150 women into three groups each of them had 50 women. Results The pain scores during IUCD insertion and during uterine sounding were lower in group A, B. There was nonhuge distinction between both groups regarding insertion result (failed, easy or difficult insertion). There was nonhuge distinction between sublingual misoprostol and lidocaine spray regarding Visual Analogue Scale during sounding the uterus and during IUCD insertion. There was nonhuge distinction between studied groups as regard of medication related side effect except misoprostol group significant increase abdominal cramps. Conclusions The study concluded that the use of sublingual misoprostol and lidocaine before IUCD insertion reduces Visual Analogue Scale scores (pain scores) during sounding the uterus and during IUCD insertion.